Individuals Stopping Slimming Jabs Regain Weight Four Times Faster Than People Using Diet and Exercise

A recent study reveals that patients who come off popular GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight far faster than those who halt conventional diet and exercise plans.

Findings released in a prominent health publication points out that while obese people often shed about a fifth of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month once they quit.

"Users using such drugs should be informed of the potential of fast weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.

Such speed of regain implies a reversion to original mass within about 18 months.

Comparing Treatments

The research, which reviewed dozens of trials involving thousands of participants, contrasted the effects of GLP-1 agonists with conventional dieting.

Researchers point out that people who shed pounds through lifestyle changes alone generally have a more gradual creep back—around 100 grams monthly—post-intervention.

The Reason for the Rapid Rebound

Nutrition scientists propose the mechanism of the injections accounts for the heightened regain.

These medications mimic a natural hormone called GLP-1, which controls appetite.

"Long-term administration of GLP-1 levels several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could diminish responsiveness to its actions," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating a significant risk."

An Ongoing Condition?

Health authorities advise the injections for individuals with obesity-related health risks, alongside recommended lifestyle changes.

Many experts argue that, given the significant potential of relapse, the treatment is often life-long.

This view is supported by pharmaceutical companies, who say that the results "emphasize the chronic nature of excess weight," similar to managing conditions like hypertension.

User Accounts

People who have discontinued the medication describe a powerful return of cravings.

"It felt as if a trigger that goes on and I was suddenly extremely hungry," described a patient.

This challenge is exacerbated if individuals have not developed lasting dietary or behavioural changes during therapy.

Widespread Use

Survey data show that millions of adults in the UK have tried these injections in the past year, with interest continuing to grow.

• Adoption is higher among females than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private healthcare rather than public health services.

Finally, clinicians caution that while the jabs are potent tools for weight loss, they are not a permanent solution and lasting health benefits relies on integrated behavioural changes.